At a glance
ClinicalIndex Comparison RecordN/ACompleted· 281 enrolled
Drug / intervention
oral cell DNA adductsother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Quantitation of Oral Cell DNA Adducts in Smokers
In Brief
An observational study evaluating oral cell DNA adducts for Lung Cancer. Completed, enrolled 281 participants across 1 site.
Detailed Summary
DNA adducts in the oral mucosa cells of 100 smokers from 3 ethnic groups - Native Hawaiians, Whites, and Japanese Americans with differing risks for lung cancer upon cigarette smoking will be quantified. DNA adducts of tobacco smoke carcinogens will be quantified using both targeted and untargeted approaches.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer
CountriesUnited States
CollaboratorsUniversity of Hawaii
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 2017
Enrollment StartFeb 2018
Primary CompletionAug 2021
TodayJul 2026
First PostedSep 18, 2017
Enrollment StartFeb 1, 2018
Primary CompletionAug 1, 2021
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 8.8 years ago
Interventions
oral cell DNA adductsother
oral cells will be collected, DNA isolated, and analyzed for adducts